{"url":"https://lda.senate.gov/api/v1/filings/dfeeea83-ecc3-4082-a5af-42dfd85e08a1/","filing_uuid":"dfeeea83-ecc3-4082-a5af-42dfd85e08a1","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/dfeeea83-ecc3-4082-a5af-42dfd85e08a1/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Beth Anne Cole","dt_posted":"2023-01-20T01:44:33-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 M Street, SE","registrant_address_2":"Suite 750","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":400534596,"url":"https://lda.senate.gov/api/v1/registrants/400534596/","house_registrant_id":41161,"name":"THORN RUN PARTNERS","description":"Government Affairs Firm","address_1":"100 M Street, SE","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"W. CHRISTOPHER LAMOND","contact_telephone":"+1 202-688-0225","dt_updated":"2026-07-09T09:06:40.882848-04:00"},"client":{"id":192638,"url":"https://lda.senate.gov/api/v1/clients/192638/","client_id":1472,"name":"THE BIOSIMILARS FORUM","general_description":"Non-profit Organization","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. H.R.2617 - Consolidated Appropriations Act, 2023, as it relates to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023. H.R.2815 - BIOSIM Act. H.R.2855 - Star Rating for Biosimilars Act. H.R.2869/S.1427 - Increasing Access to Biosimilars Act of 2021. H.R.5376 - Inflation Reduction Act of 2022","foreign_entity_issues":"Boehringer Ingelheim GmbH, Merck KGaA, Novartis AG, Samsung Bioepis, Teva Pharmaceutical Industries Ltd., as identified on LD-1, are dues paying coalition members.","lobbyists":[{"lobbyist":{"id":64036,"prefix":null,"prefix_display":null,"first_name":"STUART","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee","new":false},{"lobbyist":{"id":56748,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"DELPIZZO","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Legislative Asst, Rep. Ferguson; Staff Asst, House Transportation and Infrastructure Committee","new":false},{"lobbyist":{"id":141439,"prefix":"mrs","prefix_display":"MRS.","first_name":"THAYER","nickname":null,"middle_name":"SURETTE","last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug pricing legislation. H.R.4502 - Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022. H.R.2815 - BIOSIM Act. H.R.2855 - Star Rating for Biosimilars Act. H.R.2869/S.1427 - Increasing Access to Biosimilars Act of 2021. H.R.5376 - Inflation Reduction Act of 2022. Efforts surrounding user fees. H.R.7006 - INSPECTIONS Act.","foreign_entity_issues":"Boehringer Ingelheim GmbH, Merck KGaA, Novartis AG, Samsung Bioepis, Teva Pharmaceutical Industries Ltd., as identified on LD-1, are dues paying coalition members.","lobbyists":[{"lobbyist":{"id":64036,"prefix":null,"prefix_display":null,"first_name":"STUART","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":56748,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"DELPIZZO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141439,"prefix":"mrs","prefix_display":"MRS.","first_name":"THAYER","nickname":null,"middle_name":"SURETTE","last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}